Merck’s molnupiravir: Covid-19 gamechanger status relies on patient risk factors
Molnupiravir access may depend on how risk factors are interpreted but availability could be wider with the help of pharmacists
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
How ketamine trials are providing a blueprint for suicidal ideation research
NIMH’s Dr Elizabeth Ballard discusses how ketamine has laid the groundwork for a new paradigm of suicide research.
Asia-Pacific has seen the largest growth in cardiovascular trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
Impressive early results for Vertex’s potentially curative stem cell diabetes therapy
A cure for Type 1 diabetes has come one step closer as Vertex reports 90-day results for its synthetic insulin cell therapy.
Latest Deals
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
Weekly chart
Top countries for Environmental, Social, and Governance Jobs, June-August 2021
Source: GlobalData
| Country | Number of jobs |
|---|---|
| United States | 6607 |
| United Kingdom | 911 |
| India | 782 |
| China | 569 |
| Canada | 494 |
| Ireland | 328 |
| France | 291 |
| Switzerland | 211 |
| Germany | 196 |
| Belgium | 154 |
Latest News
Karyopharm initiates dosing in Phase II oral solid tumour medicine trial
Overall response rate will be the primary goal of Phase II trial while secondary goals are progression-free and overall survival.
Reven begins dosing in Phase II trial of anti-sepsis drug candidate
The company anticipates reporting the topline data from the Phase II trial by the end of this year.
Covid-19 booster shot improves neutralising antibody levels in NIH study
Administering a booster shot provided greater protection, indicating the ability to reduce viral replication in the lungs and nose.
Synthetic doses subjects in Phase I trial of therapy for GI diseases
The multiple-ascending dose trial will assess the repeated doses of SYN-020 in up to 32 healthy adults.
Latest Themes
Ocala Oncology to leverage Deep Lens’ VIPER solution for clinical trials
VIPER will integrate with the EMR of Ocala Oncology to select eligible patients for cancer trials.
Joe Biden’s global corporation tax deal: A prediction on what’s next
Why have the nations of the world agreed to a new minimum corporation tax rate? And what happens to so-called "Google taxes" now?
Robotics hiring levels in the clinical trial operations industry rose in August 2021
19.7% of the companies included in our analysis recruited for at least one robotics-related position.
Sagimet embraces AI-driven pathology for more consistent NASH analysis
In NASH trials, classifying patients between different fibrosis stages can be tricky due to pathologist bias.
Cloud hiring levels in the clinical trial operations industry rose to a year-high in August 2021
45.1% of the companies included in our analysis recruited for at least one cloud-related position.
AI is coming — and you can take that to the bank
AI can leverage banks' biggest asset: data, which many a startup would die for. This can save waning banks and provide new income sources.
Remote communities of healthcare professionals are enabling DCTs
Hawthorne Effect’s Hero network is enabling continuous data capture in remote and hard to reach communities.
pHOXBIO eyes UK study of preventive Covid-19 nasal spray by year’s end
The nasal spray is designed to offer hours of protection from a SARS-CoV-2 infection.
Expert Commentary & Analysis
View MoreTwitter round-up: Daniel J Drucker’s tweet on weight loss drug Wegovy the most popular tweet in Q3 2021
The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is...
Poor mental health hinders ART adherence among South Africans living with HIV
Progress on getting more HIV patients in South Africa to begin antiretroviral therapy and achieve...
Valneva’s Covid-19 vaccine will be strong competition for AstraZeneca and J&J
Valneva’s VLA2001 Covid-19 vaccine has shown better tolerability than some other vaccines, which could make...
From Pandemic to Twindemic: What Will the 2021–2022 Flu Season Bring?
Across the globe, measures that aimed to curb the transmission of COVID-19, including travel restrictions,...